Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer. Song W, Li Y, Yao Y, Sun S, et al. BMC Cancer 2024;24:680.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Song W, Li Y, Yao Y, Sun S, et al. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer. BMC Cancer 2024;24:680.
PMID: 38834983